Skip to main content

Emergency Treatments

  • Chapter
Inborn Metabolic Diseases

Abstract

As soon as the diagnosis of a metabolic disorder is suspected, an emergency management has to be scheduled. As already stated in Chap. 1, both the signs and management mainly depend on the physiopathology involved. However, this chapter focuses on the main age-related clinical presentations in neonates and children for which emergency treatment can be life saving. In neonates, four main clinical presentations can be identified.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Berry GT, Heidenreich R, Kaplan P et al. (1991) Branched-chain amino acid-free parenteral nutrition in the treatment of acute metabolic decompensation in patients with maple syrup urine disease. N Engl J Med 324: 175–179

    Article  PubMed  CAS  Google Scholar 

  2. Parini R, Sereni LP, Bagozzi DC et al (1993) Nasogastric drip feeding as the only treatment of neonatal maple syrup urine disease. Pediatrics 92: 280–283

    PubMed  CAS  Google Scholar 

  3. Ruch T, Kerr D (1982) Decreased essential aminoacid requirements without catabolism in phenylketonuria and maple syrup urine disease. Am J Clin Nutr 35: 217–228

    PubMed  CAS  Google Scholar 

  4. Khaler SG, Millington DS, Cederbaum SD et al (1989) Parenteral nutrition in propionic and methylmalonic acidemia. J Pediatr 115: 235–241

    Article  Google Scholar 

  5. Donn SM, Swartz RD, Thoene JG (1979) Comparison of exchange transfusion, peritoneal dialysis, and hemodialysis for the treatment of hyperammonemia in an anuric newborn infant. J Pediatr 95: 67–70

    Article  PubMed  CAS  Google Scholar 

  6. Saudubray JM, Ogier H, Charpentier C et al. (1984) Neonatal management of organic acidurias - clinical update. J Inherit Metab Dis 7: 2–9

    Article  PubMed  Google Scholar 

  7. Wendel U, Langenbeck U, Lombeck I, Bremer HJ (1982) Exchange transfusion in acute episodes of maple syrup urine disease: studies on branched-chain amino and keto acids. Eur J Pediatr 138: 293–296

    Article  PubMed  CAS  Google Scholar 

  8. Goertner L, Leupold D, Pohlandt F, Bartmann P (1989) Peritoneal dialysis in the treatment of metabolic crises caused by inherited disorders of organic and amino acid metabolism. Acta Pediatr Scand 78: 706–711

    Article  Google Scholar 

  9. Brusilow SW, Batshaw ML, Waber L (1982) Neonatal hyperammonemic coma. Adv Pediatr 29: 69–103

    PubMed  CAS  Google Scholar 

  10. Herrin JT, McCredie DA (1969) Peritoneal dialysis in the reduction of blood ammonia levels in a case of hyperammonaemia. Arch Dis Childhood 44: 149–151

    Article  CAS  Google Scholar 

  11. Wiegang C, Thompson T, Bock GH, Mathis RK (1980) The management of life -threatening hyperammonemia: a comparison of several therapeutic modalities. J Pediatr 96: 142–144

    Article  Google Scholar 

  12. Harris RJ (1971) Treatment in maple syrup urine disease. Lancet 2: 813–814

    Article  PubMed  CAS  Google Scholar 

  13. Wendel U, Becker K, Przyrembel H et al. (1980) Peritoneal dialysis in maple syrup urine disease: studies on branched-chain amino and keto acids. Eur J Pediatr 134: 57–63

    Article  PubMed  CAS  Google Scholar 

  14. Alexander SR (1990) Continuous arteriovenous hemofiltration. In: Levin DL, Morris FC (eds) Essential of pediatric intensive care. Quality Medical, St. Louis, Missouri, pp 1022–1048

    Google Scholar 

  15. Gouyon JB, Desgres J, Mousson C (1994) Removal of branched-chain amino acids by peritoneal dialysis, continuous arteriovenous hemofiltration, and continuous arteriovenous hemodialysis in rabbits: implications for maple syrup urine disease treatment. Pediatr Res 35: 357–361

    Article  PubMed  CAS  Google Scholar 

  16. Jouvet P, Poggi F, Rabier D et al. (1997) Continuous venovenous haemodiafiltration in the acute phase of neonatal maple syrup urine disease. J Inherit Metab Dis 20: 463–472

    Article  PubMed  CAS  Google Scholar 

  17. Ring E, Zobel G, Stöckler S (1990) Clearance of toxic metabolites during therapy for inborn errors of metabolism J Pediatr 117: 349–350

    CAS  Google Scholar 

  18. Casadevall I, Ogier H, Germain JF et al. (1992) Hemofiltration arterioveineuse continue: prise en charge dun cas de leucinose néonatale. Arch Fr Pediatr 49: 803–805

    PubMed  CAS  Google Scholar 

  19. Thompson GN, Butt WW, Shann FA et al (1991) Continuous venovenous hemofiltration in the management of acute decompensation in inborn errors of metabolism. J Pediatr 118: 879–884

    Article  PubMed  CAS  Google Scholar 

  20. Falk MC, Knight JF, Roy LP et al. (1994) Continuous venovenous haemofiltration in the acute treatment of inborn errors of metabolism. Pediatr Nephrol 8: 330–333

    Article  PubMed  CAS  Google Scholar 

  21. Sperl W, Geiger R, Maurer H et al. (1992) Continuous arteriovenous haemofiltration in a neonate with hyperammonaemic coma due to citrullinemia. J Inherit Metab Dis 15: 158–159

    Article  PubMed  CAS  Google Scholar 

  22. Roth B, Younossi-Hartenstein A, Skopnik H, Leonard JV (1987) hemodialysis for metabolic decompensation in propionic acidaemia. J Inherit Metab Dis 10: 47–151

    Google Scholar 

  23. Rutledge SL, Havens PL, Haymond MW et al. (1990) Neonatal hemodialysis: effective therapy for the encephalopathy of inborn errors of metabolism. J Pediatr 116: 125–128

    Article  PubMed  CAS  Google Scholar 

  24. Maestri NE, Hauser ER, Bartholomew D, Brusilow SW (1991) Prospective treatment of urea cycle disorders. J Pediatr 9923–928

    Google Scholar 

  25. Biggemann B, Zass R, Wendel U (1993) Postoperative metabolic decompensation in maple syrup urine disease is completely prevented by insulin. J Inherit Metab Dis 16: 912–913

    Article  PubMed  CAS  Google Scholar 

  26. Leonard JV, Umpleby AM, Naughten EM, Boroujerdy MA, Sonksen PH (1983) Leucine turnover in maple syrup urine disease. J Inherit Metab Dis 6 [Suppl 2]: 17–118

    Article  Google Scholar 

  27. Stacpoole PW, Barnes CL, Hurbanis MD, Cannon SL, Kerr DS (1997) Treatment of congenital lactic acidosis with dichloroacetate. Curr Top Arch Dis Child 77: 535–541

    Article  CAS  Google Scholar 

  28. Surtees R, Leonard JV (1989) Acute metabolic encephalopathy: a review of causes, mechanisms and treatment. J Inherit Metab Dis 12 [Suppl 11: 42–54

    Article  Google Scholar 

  29. Riviello JJ, Rezvani I, DiGeorge AM, Foley CM (1991) Cerebral edema causing death in children with maple syrup urine disease. J Pediatr 119: 42–45

    Article  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

de Baulny, H.O., Saudubray, J.M. (2000). Emergency Treatments. In: Fernandes, J., Saudubray, JM., Van den Berghe, G. (eds) Inborn Metabolic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-04285-4_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-04285-4_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-04287-8

  • Online ISBN: 978-3-662-04285-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics